The Centers for Medicare & Medicaid Services will accept comments through March 3 on its advance notice of proposed changes to Medicare Advantage plan capitation rates and Part C and Part D payment policies for calendar year 2024, which the agency estimates will increase MA plan revenues by an average 1.03%. The notice proposes updating the Part C risk adjustment model to reflect ICD-10 condition categories, 2018 fee-for-service diagnoses and 2019 FFS expenditures; and Part C and Part D Star Ratings to reflect the latest regulations. It also describes changes and additions to the standard Part D drug benefit under the Inflation Reduction Act of 2022. CMS expects to publish the final 2024 rate announcement by April 3.

Related News Articles

Headline
The companies that make the first 10 Medicare Part D drugs selected to participate in the Medicare Drug Price Negotiation Program have agreed to participate in…
Headline
The Centers for Medicare & Medicaid Services Sept. 26 released premium and cost-sharing information for Medicare Advantage and Part D prescription drug…
Headline
As millions of people are losing their Medicaid coverage as a result of the redetermination process, hospitals and health systems are seeing substantial…
Blog
More than 90 million people had access to health care through Medicaid’s pandemic-related continuous coverage provisions. That coverage ended March 31, 2023,…
Headline
This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs …
Headline
The Health and Human Services Office of Inspector General Aug. 28 released a strategic plan to align its audits, evaluations, investigations and…